一个单个对象的研究设计,评估为患有妇科癌症的成年人共同创建的课程:可行性研究协议
Jenson Price1, Jennifer Brunet2,3,4
1School of Human Kinetics, University of Ottawa, 125 University Private, Montpetit Hall, Room 339, Ottawa, ON, K1N 6N5, Canada.
Pilot and feasibility studies
|January 16, 2024
概括
这项研究评估了针对妇科癌症幸存者的社区计划,评估其可行性和对福祉的影响. 这些发现将完善未来大规模试验的计划.
科学领域:
- 在瘤学瘤学.
- 综合医学是一个整体的医学.
- 公共卫生 公共卫生
背景情况:
- 全球每年有超过130万成年人被诊断出患有妇科癌症.
- 这些诊断显著影响患者的福祉和生活质量.
- 需要支持性干预来改善幸存者护理.
研究的目的:
- 评估为妇科癌症幸存者共同创建的基于社区的计划的可行性,可接受性和忠诚度.
- 估计该计划对自我报告结果的影响.
- 为未来的大规模实施完善计划和评估方法.
主要方法:
- 一个多个基线单个主题研究设计 (ABA) 与定量和定性数据收集.
- 参与者 (n=?) 参与了一个为期12周的哈塔课程,有双模式课程.
- 数据包括每周的调查,课后的调查,采访和课堂的音频/视频录音.
主要成果:
- 追踪了可行性结果 (招聘,保留,坚持).
- 通过采访,探索了程序的可接受性,适合性和相关性.
- 自我报告的结果通过调查进行评估,并使用多层次建模分析.
结论:
- 该研究协议为评估在妇科癌症幸存者中基于社区的干预提供了一个框架.
- 数据将为程序,教练指南和评估计划的改进提供信息.
- 这项研究支持为癌症幸存者提供基于证据的支持性护理的发展.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Chest Physiotherapy
464
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
464
Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353


